HPV‐associated oropharyngeal cancer de‐escalation strategies and trials: Past failures and future promise
Kaveh Zakeri, Lara Dunn, Nancy Y. Lee
Abstract
HPV-associated oropharynx squamous cell carcinomas are radiosensitive and chemosensitive, thus, portending a favorable prognosis. Treatment de-intensification strategies aim to reduce toxicity while maintaining efficacy. Although approaches that have substituted cisplatin with cetuximab or omitted chemotherapy have not been successful, Transoral Robotic Surgery with de-intensified adjuvant therapy has been promising. Additionally, personalized approaches are taking advantage of tumor biology and utilizing tumor reduction or hypoxia on imaging as a predictive marker to successfully de-escalate radiotherapy and chemotherapy.
Topics & Concepts
CetuximabMedicineOncologyDe-escalationChemotherapyRadiation therapyInternal medicineTransoral robotic surgeryCisplatinHead and neck cancerAdjuvantCancerSurgeryColorectal cancerHead and Neck Cancer StudiesHead and Neck Surgical OncologySalivary Gland Tumors Diagnosis and Treatment